clinical_trials
Ianalumab's Road to Approval for Sjogren's Looks Bumpier
Confidence86·multiple reportsImportance88NP-EVT-20261021-10519A4
(MedPage Today) -- Findings from a pair of randomized trials in Sjögren's disease with the anti-B cell biologic ianalumab have now been published and it's no longer clear that they're sufficient to support regulatory approvals. The two trials...
Read the original at the primary source
Ianalumab's Road to Approval for Sjogren's Looks Bumpier
10/21/2026, 9:00:00 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —